Compound 28（Nanjing Medical University）

N/A

Report date: 2022/08/09 14:56:01
NME

Base Information

Drug NameCompound 28（Nanjing Medical University）
Drug Alias Name化合物28（南京医科大学）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenaseTryptophan 2,3-dioxygenase
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Medical University
Inactive CompaniesN/A
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A